An Acidic Loop and Cognate Phosphorylation Sites Define a Molecular Switch That Modulates Ubiquitin Charging Activity in Cdc34-Like Enzymes by Papaleo, Elena et al.
An Acidic Loop and Cognate Phosphorylation Sites
Define a Molecular Switch That Modulates Ubiquitin
Charging Activity in Cdc34-Like Enzymes
Elena Papaleo*, Valeria Ranzani, Farida Tripodi, Alessandro Vitriolo, Claudia Cirulli, Piercarlo Fantucci,
Lilia Alberghina, Marco Vanoni, Luca De Gioia, Paola Coccetti*
Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy
Abstract
E2 ubiquitin-conjugating enzymes are crucial mediators of protein ubiquitination, which strongly influence the ultimate fate
of the target substrates. Recently, it has been shown that the activity of several enzymes of the ubiquitination pathway is
finely tuned by phosphorylation, an ubiquitous mechanism for cellular regulation, which modulates protein conformation.
In this contribution, we provide the first rationale, at the molecular level, of the regulatory mechanism mediated by casein
kinase 2 (CK2) phosphorylation of E2 Cdc34-like enzymes. In particular, we identify two co-evolving signature elements in
one of the larger families of E2 enzymes: an acidic insertion in b4a2 loop in the proximity of the catalytic cysteine and two
conserved key serine residues within the catalytic domain, which are phosphorylated by CK2. Our investigations, using yeast
Cdc34 as a model, through 2.5 ms molecular dynamics simulations and biochemical assays, define these two elements as an
important phosphorylation-controlled switch that modulate opening and closing of the catalytic cleft. The mechanism relies
on electrostatic repulsions between a conserved serine phosphorylated by CK2 and the acidic residues of the b4a2 loop,
promoting E2 ubiquitin charging activity. Our investigation identifies a new and unexpected pivotal role for the acidic loop,
providing the first evidence that this loop is crucial not only for downstream events related to ubiquitin chain assembly, but
is also mandatory for the modulation of an upstream crucial step of the ubiquitin pathway: the ubiquitin charging in the E2
catalytic cleft.
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Introduction
A major mechanism for the promotion of protein regulation in
eukaryotes involves the covalent attachment of ubiquitin (Ub),
mediated by a hierarchical cascade of E1-E2-E3 enzymes [1,2].
In particular, the E1 enzyme activates the ubiquitin in an ATP-
dependent reaction and engages one of many cognate E2
ubiquitin-conjugating enzymes to initiate downstream events.
Ubiquitin is covalently attached to the target protein through an
isopeptide bond between the glycine in position 76 of ubiquitin
and the e-amino group of an internal lysine residue of the
target protein, through the coordinate function of E3 ubiquitin-
ligases. Several E2 cycles of E1-mediated ubiquitin loading/
unloading lead to different polyubiquitination or monoubiquiti-
nation of the substrates. By multiple runs of reactions, ubiquitin
is covalently attached to substrates to form K48-linked or K11-
linked polyubiquitinated conjugates that are addressed to
proteasomal degradation [3,4,5,6,7,8]. Moreover, post-transla-
tional modification by Ub on other lysine residues, as K63, or
ubiquitin-like proteins regulates several other processes, includ-
ing cell division, immune responses and embryonic development
[7,9,10,11].
The yeast and human genomes encode for tens of E2s, allowing
for a multitude of distinct events [12,13]. E2s have been classified
in 17 families, by a comprehensive phylogenetic analysis of several
complete genomes [14] and have been shown to present different
electrostatic potential surface properties which could be related to
their specificity [15,16]. All E2 enzymes share a conserved
catalytic core domain (Ub-conjugating domain, UBC) which
in many cases is the minimal sufficient unit for their activity,
containing the catalytic cysteine (Figure 1) and the interaction
interfaces for E1 and E3 enzymes. The 150-residues UBC domain
adopts a b/a fold (Figure 1) and the highly conserved catalytic
cysteine is located in a shallow cleft interacting with the Ub C-
terminal tail [17]. Despite conservation of the UBC domain fold,
many E2s contain sequence insertions. Yeast and mammalian
Cdc34 are multi-domain E2 enzymes, which catalyze the
formation of polyubiquitin chains on several proteins involved in
cell-cycle regulation [18]. Yeast Cdc34 is characterized by a 12-
residue insertion (residues 103–114) in the b4a2 loop of the UBC
domain, which is known as the ‘‘acidic loop’’ [19,20]. Interest-
ingly, the acidic insertion also occurs in other yeast and human
homologs and forms an extended and flexible loop [21]. In
fact, alanine-mutations of the b4a2 acidic residues abolish
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Cdc34, mutations of the acidic residues compromise the
processivity and linkage specificity of polyubiquitin chain synthesis
[22,23,24]. However, few details are still known about the
structural and functional properties of the acidic insertion. Several
E2 catalytic domains have been reported to be finely regulated by
post-translational phosphorylations [25,26,27,28]. Cdc34 is a
substrate of casein kinase 2 (CK2) [25,26,29,30,31], a highly
conserved kinase essential in several different cellular processes
[32]. In particular, CK2 phosphorylates yeast Cdc34 within the C-
terminal [26,31] and the catalytic domain (S130 and S167) [25].
S130 and S167 phosphorylations are required to stimulate yeast
Cdc34 ubiquitin-charging activity in vitro and to complement a
cdc34-2
ts mutant in vivo [25].
In light of the above scenario, we provide the first molecular
model of the regulatory mechanism mediated by CK2 phosphor-
ylation of E2 Cdc34-like catalytic domain. In particular, we show
that the acidic loop conformation is modulated by phosphorylation
of two key serine residues. Our investigation strongly suggests that
this regulatory mechanism is a conserved feature of Cdc34-like
E2s, a crucial element for the modulation of ubiquitin charging
activity.
Results
Co-evolution of phosphorylation sites and acidic loop in
Cdc34-like E2 enzymes
CK2 phosphorylation sites at S130 and S167 are functionally
relevant for the ubiquitin-charging activity of yeast Cdc34 [25].
Multiple sequence and structural alignments among representative
members of the different E2 families (Figure 2, Figure 1 in Text
S1) show that phospho-sites corresponding to S130 and S167 of
Cdc34, as well as the typical acidic consensus pattern for CK2
kinase, are strongly conserved in E2s belonging to family 3. E2
family 3 is the only family whose members show a 12/13
aminoacid insertion in the b4a2 loop (Figure 2, Figure 1 in Text
S1). In the other E2 families, which lack the acidic insertion, the
phospho-sites are poorly conserved, with the exception of E2
families (2, 4, 8, 12). The latter include members which are the
closest homologs (percentage of identity .30%) to family 3
members and which are thus characterized by a higher degree of
serine conservation (Figure 3). Interestingly, in most of the other
E2 families, which lack the acidic insertion, serines are often
replaced by non-phosphorylatable residues with no specific
physical-chemical properties (Figure 2, Figure 1 in Text S1).
These data suggest co-evolution of the phospho-sites at Cdc34 130
and 167 positions and the acidic loop in the proximity of the
catalytic site in Cdc34-like E2 enzymes.
Conformational changes of b4a2 loop modulates
accessibility of the Cdc34
UBC catalytic cleft
The striking co-presence of phosphorylation sites and the acidic
loop only in family 3 E2 enzymes, prompted us to test the
hypothesis of an interconnected structural, functional and
regulatory role of these two elements. First, the dynamic properties
of Cdc34 and its homologs have been investigated by multiple
molecular dynamics (MD) simulations of the non-phosphorylated
UBC domains (Table 1). In particular, flexibility profiles, principal
component analysis (PCA) and correlation between accessibility of
the catalytic cleft and other regions of the protein structure have
been calculated. In this context, PCA applied to MD simulations
allows the identification of the most relevant displacements of
groups of residues and emphasizes the amplitude and direction of
the dominant protein motions, by projecting them on a subset of
principal components (eigenvectors) of the Ca atoms covariance
matrix calculated from the MD conformational ensemble [33].
The conformational sub-states distribution in the proximity of the
native-state of Cdc34
UBC has been evaluated by free energy
landscape (FEL) representation using as two-dimensional (2D)
coordinates the first two principal components (PCs) derived by
PCA(Figure 2 inText S1), aswell as from structural cluster analysis.
The structural cluster analysis and the FEL representation
Figure 1. Summary structure of 3D UBC domain architecture.
The 3D architecture of UBC domain of the E2 superfamily, as well as
secondary structure elements and the conserved residues are shown. a-
helices are labeled H1 to H4 (with h for a 3.10 helix common to some E2
structures) and b-strands are labeled S1 to S4. The catalytic cysteine (C),
a strictly conserved tryptophan residue (W) and the HPN (His-Pro-Asn)
motif in the proximity of the catalytic site, as well as the proline rich
motif (PPxxP) are indicated [14]. The structure is adapted from the 3D
structure of Ube2g2 (PDB code 2CYX).
doi:10.1371/journal.pcbi.1002056.g001
Author Summary
A major mechanism for promoting protein regulation in
eukaryotes involves the labeling with ubiquitin molecules
of target proteins. Protein ubiquitination is involved in
almost all aspects of eukaryotic cellular functions and is
mediated, at the molecular level, by a hierarchical cascade
of three different enzymes. Among these enzymes, E2
ubiquitin-conjugating enzymes are located at the heart of
the ubiquitination pathway and are key mediators of
protein ubiquitination, which strongly influence the
ultimate fate of the target substrates. Since several E2s
have also been related to a variety of cancer and
neurodegenerative disorders, increasing efforts are being
devoted to the understanding of E2 regulation at the
molecular level, a mandatory step for a complete
understanding of the ubiquitination process. In the
present contribution, we propose, by computational and
biochemical investigations, a conserved mechanism of
regulation by phosphorylation of the catalytic activity of a
class of E2 enzymes, which plays a major role in the
regulation of cell cycle progression and tumor develop-
ment. Our results shed new light on and clarify molecular
aspects related to one of the first steps of the ubiquitina-
tion cascade and its regulation.
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UBC exists in several sub-states in solution
(Figure 2 in Text S1, Figure 4A). In particular, it is possible to
identify five main structural ensembles (labeled A–E) which
correspond to the minimum free energy basins and the most
populated structural clusters from cluster analysis. These
structural ensembles capture the most relevant conformational
and dynamical features of Cdc34
UBC. The major differences
among the ensembles are related to different conformations of the
b4a2 loop (Figure 4A).
Interestingly, the b4a2 loop close to the E2 active site, and in
particular its acidic insertion (residues 103–114) is characterized by
a high conformational variability (Figure 4A), that can be
described quantitatively by flexibility indexes as root mean square
fluctuation (rmsf) calculated on each Cdc34
UBC ensemble
trajectory (Figure 4B, Figure 3 in Text S1). MD simulations of
Cdc34 homologs with known 3D structure (yeast Ubc7 and
human Ube2g2) (Figure 4B) confirmed that the b4a2 loop features
the highest conformational freedom also in other family 3
members. These results are in good agreement with evidence
from X-ray crystallographic investigations of these enzymes
[34,35], in which the regions corresponding to the acidic loop
seem to be disordered and associated to high B-factor values.
Moreover, recent NMR studies of free Ube2g2 [21] or Ube2g2 in
complex with a domain of its E3 partner [36] suggest the
possibility of conformational changes of the b4a2 loop. However,
the MD simulations carried out in the present work, allow a higher
sampling of the conformation accessible to the b4a2 loop,
highlighting larger structural rearrangements.
Figure 5A shows solvent accessibility of the catalytic C95 side
chain as a function of the distances between the C95 and the acidic
insertion. Solvent accessibility increases as the acidic loop ‘‘moves
away’’ from the active site. We refer to conformations of the b4a2
loop in proximity of - and away from - the catalytic cysteine as
‘‘closed’’ and ‘‘open’’ conformations, respectively. Since PCA
makes it possible to identify amplitude and direction of relevant
protein motions, the projections of the first principal component
(PC1) on the 3D structure of Cdc34
UBC have been analyzed.
Protein motions governing PC1 are related to rearrangements and
oscillations of the acidic loop over the catalytic site (Figure 5B) that
make it function as a ‘‘lid’’ modulating the accessibility of the Ub-
binding cleft.
Phosphorylation of Cdc34
UBC improves accessibility of
the catalytic site by displacing the acidic loop
In Cdc34
UBC simulations, some residues within the acidic insert
(D104, D108, E109, D111 and E113), came transiently close to
the catalytic cleft (Figure 5A, Figure 6) and, therefore also to the
a-helix in which S130 is located. This observation suggests that
S130 phosphorylation, introducing a strongly negatively charged
group, may result in electrostatic repulsion with the above-
mentioned acidic residues, favoring the open conformation of the
b4a2 loop. This hypothesis was tested by MD simulations of
phospho-variants of the Cdc34
UBC (Table 1) that were compared
with simulations of the non-phosphorylated Cdc34
UBC, as well as
with simulations of the Cdc34
UBC alanine mutants, in which the
phosphorylation sites (S130 and S167) are abolished, and that
have been used in biochemical and genetic experiments [25].
While alanine substitutions do not influence secondary structure
content and flexibility patterns described for native Cdc34
UBC
(Figure 4B), flexibility profiles of Cdc34
UBC-pS130 indicate that
phosphorylation strongly reduces atomic fluctuations, structurally
stabilizing the whole 3D architecture and in particular the acidic
Figure 3. Conservation of phospho-sites and of CK2 consensus
pattern. The conservation degree of S/T residues at positions
corresponding to Cdc34 S130 (Psite-1) and S167 (Psite-2), as well as
of acidic residues of the CK2 consensus pattern (DE1 and DE2) has been
calculated from the intra-family sequence alignments in Figure 4S.
doi:10.1371/journal.pcbi.1002056.g003
Figure 2. Multiple sequence alignment of family 3 E2s. Identical
residues (grey-filled boxes) and similar residues (grey boxes) are
indicated.
doi:10.1371/journal.pcbi.1002056.g002
Regulatory Mechanisms by Phosphorylation of Cdc34
PLoS Computational Biology | www.ploscompbiol.org 3 May 2011 | Volume 7 | Issue 5 | e1002056insertion (103–114) (Figure 7A). Phosphorylation of both S130 and
S167 (Figure 4 in Text S1, Figure 7B) has comparable effects on
acidic loop conformations compared to those observed for
phosphorylated Cdc34
UBC-pS130 (Figure 7), with a slightly higher
capability of reducing protein flexibility of b4a2 loop of the
double-phospho variant with respect to Cdc34
UBC-pS130.
The comparison between snapshots of Cdc34
UBC and phospho-
Cdc34
UBC simulations revealed that, in the phospho-Cdc34
UBC
versions, the loop is stabilized in an open conformation (Figure 8A,
in blue), determining a higher solvent accessibility of the catalytic
residue C95. It is worth mentioning that phospho-Cdc34
structures have an average value of C95 solvent accessibility
(avSAS=30%) comparable to the average value calculated for the
40 ns simulation of yeast Ubc1 (avSAS=34%), a family 2 E2
lacking the acidic insertion. Interestingly, solvent accessibility
values of the catalytic cysteine side-chain in native Ube2g2 NMR
structure [21], as well as in Ube2g2 in complex with a domain of
its E3 partner [36] are lower than 15%, indicating that
phosphorylation in the Cdc34 catalytic domain promotes a more
relevant outward conformational displacement of the acidic loop
than previously shown (Figure 5 in Text S1).
These data are confirmed by the analysis of the motions
described by the PC1 of phospho-Cdc34
UBC simulations
(Figure 8B). Fluctuations along PC1 are strongly reduced and
Table 1. Summary of MD simulations and simulated systems.
Cdc34 variant Number of replicas Duration per replica Total duration Starting structure
*Cdc34
UBC 12 20 ns 0.24 ms Cdc34 models using C.elegans Ubc7 (replicas 1–4), Ube2g
(replicas 5–8) and S. cerevisiae Ubc7 (replicas 9–12) as
templates
Cdc34
UBC-pS130-pS167 11 50 ns 0.55 ms Average structure from ensembles A (replicas 1–3), B
(replicas 4–5) and C (replicas 6–7), D (replicas 8–9), and E
(replicas 10–11)
Cdc34
UBC-pS130 10 50 ns 0.50 ms Average structure from ensembles A (replicas 1–2), B
(replicas 3–4) and C (replicas 5–6), D (replicas 7–8), and E
(replicas 9–10)
Cdc34
UBC-S130A-S167A 4 50 ns 0.20 ms Average structure from ensemble A
Cdc34
UBC-pS130-S167A 4 50 ns 0.20 ms Average structure from ensemble A
Cdc34
UBC-S130D 4 50 ns 0.20 ms Average structure from ensembles A (replicas 1–2) and D
(replicas 3–4)
Ubc7 4 40 ns 0.16 ms X-ray structure of S.cerevisiae Ubc7 (pdb entry 2UCZ)
Ube2g2 4 40 ns 0.16 ms X-ray structure of human Ube2g2 (pdb entry 2CYX or 1KLY)
Cdc34D12
UBC 1 100 ns 0.1 ms Average structure from ensemble A
Ubc1 1 40 ns 0.04 ms X-ray structure of the catalytic domain of S.cerevisiae Ubc1
(pdb entry 1FYZ)
*In order to evaluate stability of the Cdc34
UBC replicas, sample simulations using as starting structure the Cdc34 model which has been generated using as template
Ube2g2 NMR structure have been extended to 80 and 100 ns.
doi:10.1371/journal.pcbi.1002056.t001
Figure 4. Cdc34
UBC simulations. (A) Average structures from Cdc34
UBC simulations. The acidic loop is shown in blue and its amino acid sequence
is indicated in the box on the left. Acidic and polar residues of the acidic loop are shown in green. (B) Ca rmsf profiles computed on Ubc7, Ube2g2
and Cdc34
UBC-S130AS167A macro-trajectories in comparison to Cdc34
UBC. The most persistent secondary structures during the simulations are
represented for each system. The rectangular box indicates the acidic loop.
doi:10.1371/journal.pcbi.1002056.g004
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of the acidic loop typical of Cdc34
UBC, whereas a displacement of
the loop toward open conformations is evident (Figure 5, 8B and
D). In order to assess that effects induced by S130 phoshorylation
are mainly due to electrostatic repulsion between acidic residues in
the loop and the negatively charged pS130, simulations of mutant
Cdc34




carried out. The dynamical and structural properties of
Cdc34
UBC-S130D and Cdc34
UBC-S130E, as well as the stabiliza-
tion of the loop in an open conformation, are in agreement with
data derived from phospho-Cdc34
UBC simulations (Figure 7B, 8C
and Figure 6 in Text S1).
To quantitatively define differences in the solvent accessibility of
catalytic cysteine and displacement of the acidic loop from the
catalytic site, the distributions of the solvent accessibility of the
catalytic C95 side chain as a function of the distances between C95
and the acidic insertion have been compared in non-phosphor-
ylated, phospho- and S130E Cdc34
UBC variants (Figure 8D).
Interestingly, the distribution of C95 SAS as a function of the
distance between C95 and the acidic loop (Figure 8D), in
agreement with analysis of rmsf profiles (Figure 7B), highlights a
slightly greater displacement toward open conformations induced
by the double-phospho variants. Moreover, the analysis suggests
that the mutation of serine to acidic (for example glutamate)
residues has lower effects in promoting acidic loop displacement
than do the phospho-variants, which is probably related to
enhanced electrostatic repulsion induced by the replacement of a
poly-anionic phospho-serine with a mono-anionic residue (as Asp
or Glu).
Our results suggest that the activation of Ub-conjugation
activity by S130 phosphorylation is triggered by electrostatic
repulsive effects between the phospho-Ser and the acidic residues
of the b4a2 loop, promoting an outward displacement of the loop
and a competent conformation of the catalytic cleft for Ub-
charging.
In vitro activation of Ub-charging activity of Cdc34 by
CK2 phosphorylation requires the acidic loop
According to the above-described model, phosphorylation by
CK2 of the catalytic domain of Cdc34 can induce an outward
displacement of the acidic loop, promoting Ub access to the
catalytic cleft. Thus, to experimentally test the model, we
investigated the effect of CK2 phosphorylation on the efficiency
of Ub-charging of a protein lacking the 12 residue insertion in the
acidic loop (His6-Cdc34-D12). It is known that Cdc34-D12 is a
Figure 5. Conformational variability of the acidic loop and C95 solvent accessibility. (A) Distance between the centers of mass of C95 and
the acidic loop as a function of solvent accessible surface (SAS) of C95 sidechain. (B) Projections of the simulations frames along the PC1 of Cdc34
UBC
concatenated trajectory, indicated with different shades of magenta. The open and closed conformations of the acidic loop are indicated.
doi:10.1371/journal.pcbi.1002056.g005
Figure 6. Mechanism of acidic loop activation by electrostatic
repulsive effects. An average structure from Cdc34
UBC simulations is
reported in which acidic residues (D104, D108, E109, D111 and E113) of
the acidic loop, as well as S130 and catalytic C95, are shown. Acidic
residues of the acidic loop come transiently close to the a-helix in which
S130 is located.
doi:10.1371/journal.pcbi.1002056.g006
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the deletion of the acidic loop does not significantly change the
overall structure of Cdc34 catalytic domain in a 100 ns MD
simulations of Cdc34-D12
UBC (Figure 7 in Text S1). In a thiolester
assay, Cdc34 migrates as a set of discrete bands, which are due to
the linkage of multiple ubiquitin groups to lysine residues in Cdc34
protein. These autoubiquitination products depend upon the
binding of the Ub molecule to the catalytic residue C95 [39,40].
As previously reported [25], phosphorylation by CK2 strongly
enhanced the ubiquitin-charging activity of His6-Cdc34 in a
thiolester assay in vitro, mainly acting through S130 and S167
phosphorylations (Figure 9A). The Ub-charging activity of the
mutant protein His6-Cdc34-D12 is unaffected by phosphorylation,
since both the phosphorylated and unphosphorylated proteins are
able to bind Ub to a comparable level (Figure 9A). To ascertain
which of the many bands is the thiolester form, the samples of the
thiolester assays were separated on both reducing and non
reducing conditions (Figure 9B). The only species sensitive to
DTT is the faster migrating band, corresponding to the Cdc34-Ub
thiolester, as also reported by Banerjee et al. [39]. These results
support the conclusions derived from MD investigation, indicating
that the main role of CK2 phosphorylation on Cdc34
UBC is to
promote the displacement to an open conformation of the acidic
loop and to expose the catalytic cysteine to the solvent.
Discussion
E2 enzymes define a complex superfamily that includes 17
families [14]. They play a major role in protein ubiquitination and
Ub chain assembly [12,13]. Recently, E2s have been shown to be
involved in a variety of disorders, including cancers and
neurodegenerative diseases [41,42,43]. Accordingly, there is
increasing interest in understanding their regulation at the
molecular level, a mandatory pre-requisite for rational design of
effective pharmacologically active molecules which target E2
function.
An acidic insertion in the loop b2a4 has been identified in the
proximity of the catalytic cysteine of several E2 enzymes, including
Cdc34 that plays a major regulatory role in cell cycle progression
and tumor development [41,42]. The acidic loop has been
thoroughly investigated by mutagenesis experiments. In fact,
mutations of acid residues in the loop abolished the polyubiquitin
chain assembly, the processivity and the synthesis of a poly-
ubiquitin chain with a correct topology [22,23,24]. It has been
proposed that the loop is crucial for E2 downstream signaling such
as interactions with E3 or correct interactions with the target
substrates. Nevertheless, the 12-residue acidic insertion is not
essential for yeast Cdc34 function in over-expression conditions
[37] and its role in Cdc34 function remains unexplained.
In this paper, we report that the loop acts as one element of a
bipartite signature structure conserved among the Cdc34-like E2
enzymes belonging to family 3 and regulates enzyme activity
through a phosphorylation mechanism. The second component of
the signature structure is defined by serines within the catalytic
domain, corresponding to S130 and S167 of yeast Cdc34, which
are phosphorylated by CK2, a highly conserved protein kinase,
essential in several different cellular processes. Together these two
elements define a molecular switch that modulates opening and
closing of the catalytic cleft, and whose dynamics can be finely
regulated by CK2 phosphorylation (see below).
In the unphosphorylated protein, the b4a2 loop has high
conformational freedom (Figure 4, 5A). MD trajectories show that
acidic residues of the loop came close to S130 of Cdc34 located in
an a-helix forming one side of the catalytic cleft (Figure 5-6). These
movements make the loop act as a ‘‘lid’’, switching from ‘‘open’’ to
‘‘closed’’ conformations with respect to the catalytic cleft
(Figure 10). The mobility of the acidic loop in Cdc34
UBC and its
modulation of solvent accessibility of the E2 catalytic cleft could
explain the low basal Ub charging activity by unphosphorylated
Cdc34 observed in vitro [25], also in agreement with the fact that
the NMR structure of the human homolog Ube2g2, an E2 enzyme
belonging to family 3, is characterized by conformations of the
acidic insertion which in general does not provide accessibility of
the catalytic cysteine [21].
Repulsive electrostatic effects between phospho-S130 and the
acidic residues in the loop decrease its mobility, triggering an
outward displacement of the loop and a competent conformation
for Ub-charging (Figure 10). The proposed mechanism for Cdc34-
like E2s activation is also in agreement with preliminary homology
models of complexes between Cdc34-like enzymes and Ub, in
which only open conformations of the loop are compatible with
Figure 7. Flexibility profiles of phospho-Cdc34
UBC variants. (A) Ca rmsf of the ensemble trajectories of Cdc34
UBC-pS130 and Cdc34
UBC. (B) Ca






persistent secondary structures during the simulations are represented schematically for each system. The rectangular box indicates the acidic loop.
doi:10.1371/journal.pcbi.1002056.g007
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agreement as well with the previous observation that the acidic
loop in a more closed conformation would result in steric clashes
with the C-terminus of the ubiquitin molecule [36]. Our proposed
model further predicts that if the electrostatic repulsive effects,
which promote conformational changes of the loop, are abolished
by mutations of the phospho-sites or of the acidic residues in the
insertion, the loop cannot be stabilized in an open conformation
upon phosphorylation, compromising downstream events in the
Ub pathway. Consistently with this notion, while Cdc34 Ub-
charging activity is modulated by CK2-dependent phosphoryla-
tion of S130 (and S167, see later) [25], ubiquitin charging activity
of His6-Cdc34-D12 is unaffected by phosphorylation (Figure 9).
It has also to be considered, in our model, that ubiquitin-
charging of E2 enzymes requires an interaction between E2 and
E1 enzyme and a transfer of ubiquitin from the E1 catalytic
cysteine to the E2 catalytic cysteine. In order, to strengthen our
model, we derived by similarity with experimentally known E1-E2
complexes, a model of the putative complex between Uba1 E1
enzyme and Cdc34 with both open and closed conformations of
the acidic loop (Figure 8 in Text S1). This qualitative model
suggests that the acidic loop can be accommodated in the E1
binding cavity both in the open and closed conformation without
causing steric effects, but if the loop is in a closed conformation it is
likely to create a barrier between the E1 and E2 catalytic cysteines
and probably prevents the transfer of Ub molecule. As it can be
Figure 8. Phospho-Cdc34
UBC simulations. (A) Average structure from Cdc34
UBC-pS130 (blue) simulations in comparison to a Cdc34
UBC (magenta)
reference structure with the loop in a closed conformation. (B) Projection of the simulations frames along the PC1 of Cdc34
UBC-pS130 concatenated
trajectory, indicated with different shades of blue. (C) Projections of the simulations frames along the PC1 of Cdc34
UBC-S130E concatenated trajectory
indicated with different shades of grey. (D) Solvent accessible surface (SAS) of C95 sidechain in comparison to the distance between the centers of
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Cdc34 of serine or phospho-serine does not significantly affect the
intermolecular interaction network at E1-E2 interface, even if
further calculations will be necessary to clearly define the
intermolecular interactions in details, whereas Uba1-Cdc34 model
emphasizes the notion that the prominent role of S130
phosphorylation is to promote the acidic loop displacement (data
not shown). Previous results showed that in vivo both S130 and S167
residues need to be mutated to alanine to make the yeast Cdc34
protein unable to complement a cdc34-2
ts mutant, although
evident morphological defects were observed in strains expressing
Cdc34
S130A (but not Cdc34
S167A) [25]. Phosphorylation of S130
residue is likely to account for the most relevant conformational
changes induced by the post-translational modification, whereas
S167 may have additive enhancing effects as suggested by double-
phosphorylated Cdc34 MD simulations. In our model, S167 is
located close to the C-terminal end. As a result, constraints on
S167, as well as its interactions with other protein domains are
likely to be lost. A detailed computational study of the role of S167
phosphorylation will require a suitable structure of the full-length
Cdc34 protein.
In a broader context, it has been established that post-
translational phosphorylation is a widespread mechanism for the
regulation of protein biological activity [44,45]. In several cases,
enzyme activity or protein function has been reported to be
regulated by inhibitory or activatory phosphorylation events at
specific protein sites. At the molecular level, these events are
mediated by electrostatic repulsion between the phospho-residues
and the neighboring negatively charged aminoacids [46,47,
48,49,50,51], pointing out a general and important regulatory
mechanism. These mechanisms can be successfully investigated in
atomic details by MD simulations [47,52].
In conclusion, our study sheds a new and unexpected light on
the role of the acidic loop in Cdc34-like E2 enzymes and provides
the first evidence that this loop is crucial not only for downstream
events related to Ub chain assembly [20–22], but above all for
modulation of an upstream crucial step of the Ub pathway: the
covalent Ub-binding of Cdc34-like E2s. The loop activation by
phosphorylation of serine residues in the UBC domain is a
mandatory step for an efficient Ub-charging and could also
account for the proper proceeding of downstream events in the
ubiquitin pathway.
Materials and Methods
Homology modeling of yeast Cdc34 and alignments
Three different models have been generated with Modeller [53]
for yeast Cdc34 UBC domain (7–170 residues, Cdc34
UBC) using as
templates the known X-ray structures of human Ube2g2 [PDB
entry 2CYX [32]], yeast Ubc7 [PDB entry 2UCZ [33]] and C.
elegans Ubc7 [PDB entry 1PZV (to be published)] enzymes, sharing
with yeast Cdc34 more than 40% of sequence identity (Text S2).
Multiple sequence and structural alignments of 250 sequences of
E2 UBC domains from each of the known 17 E2 families [13]
have been performed by ClustalW [54] and DALI [55]. E2s from
families 10, 16 and 17 have been discarded, as they are not
catalytically active or characterized by a non canonical fold [13].
In particular, UBC domain sequences of each E2s have been
determined by intra-family sequence alignments. For each family,
a sequence alignment between Cdc34 and the members of the
family has also been carried out (Figure 1 in Text S1).
Molecular dynamics simulations
Molecular dynamics (MD) simulations were performed using
GROMACS 3.3.3 (www.gromacs.org) with a modified version of
GROMOS96 force field [56,57]. The Cdc34 models (Cdc34
UBC)
and the 3D crystallographic structures of yeast Ubc7 and human
Ube2g2, as well as of yeast Ubc1 [PDB entry 1FZY[15]] have
been used as starting point for simulations. The structures were
soaked in a dodechaedral box of SPC (Simple Point Charge) water
molecules [58] in periodic boundary conditions (Text S2). In the
simulations all the protein atoms were at a distance equal or
greater than 0.6 nm from the box edges. Productive MD
simulations were performed in the isothermal-isobaric (NPT)
(300 K, 1 bar and 2 fs time-step). Electrostatic interactions were
calculated using the Particle Mesh-Ewald (PME) summation
scheme [59]. Van der Waals and Coulomb interactions were
truncated at 1.0 nm and conformations stored every 4 ps. 4
independent simulations (replicas) were carried out for each non-
phosphorylated Cdc34 model (Table 1), in order to improve the
conformational sampling. MD multiple-replica approach has been
shown to allow a wider conformational sampling than only few
longer molecular dynamics simulations, if the stability of the
trajectory and convergence of the analyzed properties have been
carefully verified [60,61,62,63]. The integration of structural
cluster analysis and free energy landscape (Text S2, Figure 2 in
Text S1) has been used in order to identify representative
structures of Cdc34
UBC close to its native-state, according to a
protocol previously published [64]. In particular, an iterative
procedure was pursued, collecting independent replicas for the
same protein system until parameters from principal component
analysis reach convergence (see below) and results from cluster
analysis and free energy landscape are congruent (Text S2,
Figure 2 in Text S1).
The average structures from native Cdc34
UBC simulations have
been used as starting structures for simulations of Cdc34
UBC
mutant and phospho-variants. The replicas collected for each
protein and mutant variant differ for duration and number
(Table 1), allowing us to collect more than 2.5 ms of simulations.
MD simulations using the same approach have been also
carried out on the two Cdc34 homologs yeast Ubc7 and human
Ube2g2 for which known experimental structures are available.
Moreover, since an NMR structure of Ube2g2 has been released
during the manuscript preparation (PDB entry 2KLY [19]),
control simulations have been also carried out starting from a
model of Cdc34 using the Ube2g2 NMR structure as template,
allowing to confirm the collected results (data not shown).
Analysis of MD simulations
The rmsd (root mean square deviation) has been calculated with
respect to the MD initial structures, both using all protein
mainchain atoms (Figure 9 in Text S1) and mainchain atom of the
Figure 9. CK2 phosphorylation does not stimulate Cdc34-
ubiquitin charging activity of a His6-Cdc34-D12 protein. (A)
Recombinant His6-Cdc34 and His6-Cdc34-D12, either phosphorylated in
vitro by CK2 or not, were incubated with E1, ATP and biotinylated
ubiquitin. Samples were taken at the indicated time points. Data are
representative of one of three experiments performed. (B) Recombinant
His6-Cdc34 was treated as in (A) except that DTT (200 mM) was added
to protein samples prior to electrophoresis.
doi:10.1371/journal.pcbi.1002056.g009
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(Cdc34
UBC and Ubc7) to 10 ns (mutant and phospho-Cdc34
UBC)
of each replica are required for convergence. For each system, the
equilibrated portions of each replica were joined in macro-
trajectories, representative of different directions of sampling
around the starting structure. In order to carefully checked rmsd
profiles stability, sample simulations have been extended to 80/
100 ns, indicating that the proteins are not still in a slow
equilibration phase and that the resulting trajectories can be used
to investigate dynamic and structural properties.
The secondary structure content was calculated by DSSP
program (http://swift.cmbi.ru.nl/gv/dssp/). The root mean
square fluctuation (rmsf) per residue from the average structure
was calculated on a-carbons (Ca). In order to verify consistency of
rmsf profiles, the Pearson correlation coefficient was calculated for
rmsf data sets relative to replicas of the same system, collecting
values higher than 0.6 (Text S2 for further details on MD
analyses).
Principal Component Analysis (PCA) and Free Energy
Landscape (FEL)
PCA reveals high-amplitude concerted motion in MD trajec-
tories, through eigenvectors of the Ca mass-weighted covariance
matrix of atomic positional fluctuations [33] calculated for each
Figure 10. Model of the activation mechanism of ubiquitin charging activity of Cdc34-like E2 enzymes. Ubiquitin, unphosphorylated
and phosphorylated Cdc34-like E2s are shown in yellow, magenta and blue, respectively. (A) In unphosphorylated E2 enzyme, the acidic loop can
interconvert between open and closed conformations with respect to the catalytic site and ubiquitin charging is strongly disadvantaged. (B) Upon
phosphorylation, the E2 enzyme is stabilized in an open conformation of the acidic loop, competent for ubiquitin charging, induced by electrostatic
repulsion, which do not allow the closure of the loop on the catalytic cleft.
doi:10.1371/journal.pcbi.1002056.g010
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trajectories the first 3 principal components (PCs) describe more
than 60% of the total motion. Cosine content of the first 20 PCs
has been calculated to evaluate the conformational sampling
achieved by simulations (Text S2, Figure 11 in Text S1).
Recombinant DNA techniques, genetic manipulations
and purification of His6-Cdc34-D12
DNA manipulations and yeast transformations were carried out
according to standard techniques. E. coli DH5a and BL21(DE3)
[pLysE] were used in cloning experiments and for expression of
recombinant proteins, respectively. CDC34-D12 (containing
CDC34 gene with the deletion of the sequence encoding
aminoacids 103–114) was cloned in pIVEX2.4a plasmid using
custom designed primers. His6-Cdc34-D12 recombinant protein
was purified as previously reported [23].
In vitro phosphorylation and thiolester assay
In vitro phosphorylation of recombinant proteins (7 mg of each
purified protein) was performed as previously described [23], using
10 U of purified human CK2 (BIOMOL) in 10 mM Tris-HCl pH
7.5, 150 mM NaCl, 10 mM MgCl2, 100 mM ATP for 30 min at
30uC. CK2 phosphorylation was controlled using [c-
32P]-ATP.
Both phosphorylated and not phosphorylated His6-Cdc34 and
His6-Cdc34-D12 recombinant proteins were used in a thiolester
assay. The reaction mixture contained the following in a volume of
40 ml: 50 mM Tris-HCl pH 7.5, 5 mM MgCl2, 2 mM DTT,
0.5 mM ATP, 20 ng/ml biotinylated-ubiquitin, 10 ng/mlE 1
enzyme, 50 ng/ml His6-Cdc34 or His6-Cdc34-D12. After incuba-
tion at 37uC for the indicated time points, the reaction was
stopped by the addition of sample buffer without b-mercaptoeth-
anol (where indicated, 200 mM DTT was added). Samples were
subjected to SDS-PAGE and analyzed by decoration with
Horseradish-Peroxidase (HRP)-streptavidine.
Supporting Information
Text S1 This file contains the following supporting figures for
this article: Figure 1. Intra-family multiple sequence alignment. In
each alignment the families are indicated by ‘_x’. Figure 2.
Conformational landscape explored in Cdc34
UBC simulations.
The free energy landscape is represented using projection of the
Cdc34
UBC macro-trajectory along the principal components PC1
and PC2 of the essential subspace. The free energy is given in KJ/
mol and indicated by the color bar. The label A–E indicates the
region corresponding to the minimum free energy basins and the
most populated structural clusters from cluster analysis. Figure 3
Flexibility profiles of non-phosphorylated Cdc34
UBC.C a rmsf of
ensemble trajectories of Cdc34
UBC and Cdc34
UBC–S130AS167A
concatenated trajectories. The most persistent secondary structure
during the simulations are represented schematically for each
protein system. The rectangular box indicates the acidic loop.
Figure 4. Flexibility profiles of phospho-Cdc34
UBC–pS130pS167
simulations. Ca rmsf of ensemble trajectories of Cdc34
UBC-pS130-
pS167 and non-phosphorylated Cdc34
UBC are compared. The
most persistent secondary structure during the simulations are
represented schematically for each protein system. The rectangu-
lar box indicates the acidic loop. Figure 5. 3D structural
superimposition of an average structure from phospho-Cdc34
UBC
simulations, free NMR and X-ray structure of Ube2g2 and
Ube2g2 in complex with the gp78 region of its E3 partner. The
average structure of phospho Cdc34
UBC simulations is shown in
blue, the NMR (PDB entry 2KLY) and X-ray (PDB entry 2CYX)
structure of Ube2g2 are shown in dark and light green,
respectively, the structure of Ube2g2 in complex with gp78 region
of E3 partner (PDB entry 3H8K) is shown in orange. The catalytic
cysteine is shown as yellow stick. Figure 6. Projection of the
simulations frames along the PC1 of Cdc34
UBC-S130D concate-
nated trajectory, indicated with different shades of grey. The
rectangular box indicates the acidic loop and its aminoacidic
composition. Figure 7. Root mean square fluctuation (rmsf)
profiles of Cdc34
UBC and Cdc34-D12
UBC domains. Figure 8.
Model of Cdc34 both in closed (A) and open (B) conformations in
complex with Uba1 E1 on the base of the known crystallographic
structures of E2-E1 enzymes (PDB codes: 3CMM (Uba1) and
2PX9 (Ubc9 E2 in complex with SAE2 E1) and 2NVU (Ubc12 E2
in complex with Uba3 E1 and Nedd8). Figure 9. Mainchain root
mean square deviation of single replicas of each simulated protein
system. Figure 10. Mainchain root mean square deviation of the
structural elements of the common E2-fold (the mainchain atoms
of the acidic loop are not included in the analysis) of the Cdc34
simulations. Figure 11. Cosine content along the first 20 principal
components of single replicas and concatenated trajectories of
different length for each simulated protein system.
(PDF)
Text S2 Homology modeling of Cdc34
UBC to generate starting
structures for molecular dynamics simulations and molecular
dynamics simulations setup and analysis.
(PDF)
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